Fermín Goytisolo
Corporate Officer/Principal at PANGAEA ONCOLOGY, S.A.
Fermín Goytisolo active positions
Companies | Position | Start | End |
---|---|---|---|
PANGAEA ONCOLOGY, S.A. | Corporate Officer/Principal | - | - |
Career history of Fermín Goytisolo
Former positions of Fermín Goytisolo
Companies | Position | Start | End |
---|---|---|---|
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Corporate Officer/Principal | - | - |
Najeti Capital SA
Najeti Capital SA Investment ManagersFinance Najeti Capital SA, formerly Najeti Capital SCR SA, invests in technology-driven, expansion projects with proprietary technologies across Europe with a special focus on Spain. It focuses on the sectors of biotechnology, telecommunications, media & technology (TMT) and services. The investment size ranges from €4 million to €8 million. It provides financing for growth or expansion capital requirements. It prefers to co-invest with other investors. | Corporate Officer/Principal | - | - |
Metas Biotech SL | Corporate Officer/Principal | - | - |
Statistics
International
Spain | 4 |
2 |
Operational
Corporate Officer/Principal | 4 |
Sectoral
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PANGAEA ONCOLOGY, S.A. | Health Technology |
Private companies | 3 |
---|---|
Metas Biotech SL | |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
Najeti Capital SA
Najeti Capital SA Investment ManagersFinance Najeti Capital SA, formerly Najeti Capital SCR SA, invests in technology-driven, expansion projects with proprietary technologies across Europe with a special focus on Spain. It focuses on the sectors of biotechnology, telecommunications, media & technology (TMT) and services. The investment size ranges from €4 million to €8 million. It provides financing for growth or expansion capital requirements. It prefers to co-invest with other investors. | Finance |
- Stock Market
- Insiders
- Fermín Goytisolo
- Experience